BerGenBio ApS — Credit Rating and Financial Key Figures
CVR number: 44311747
Njalsgade 21 F, 2300 København S
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | 6 481.55 |
| Employee benefit expenses | -6 289.72 |
| EBIT | 191.83 |
| Other financial income | 10.49 |
| Other financial expenses | -0.27 |
| Pre-tax profit | 202.05 |
| Income taxes | -48.27 |
| Net earnings | 153.78 |
Assets (kDKK)
2024 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Current trade debtors | 337.63 |
| Prepayments and accrued income | 11.71 |
| Short term receivables total | 349.34 |
| Cash and bank deposits | 256.19 |
| Cash and cash equivalents | 256.19 |
| Balance sheet total (assets) | 605.54 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 40.00 |
| Retained earnings | -6.36 |
| Profit of the financial year | 153.78 |
| Shareholders equity total | 187.41 |
| Non-current liabilities total | |
| Current trade creditors | 12.79 |
| Short-term deferred tax liabilities | 48.27 |
| Other non-interest bearing current liabilities | 357.07 |
| Current liabilities total | 418.13 |
| Balance sheet total (liabilities) | 605.54 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.